Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 5
1981 2
1982 7
1983 5
1984 8
1985 15
1986 20
1987 27
1988 27
1989 31
1990 39
1991 42
1992 46
1993 64
1994 93
1995 62
1996 80
1997 109
1998 101
1999 89
2000 101
2001 134
2002 140
2003 181
2004 141
2005 160
2006 188
2007 150
2008 144
2009 123
2010 118
2011 125
2012 99
2013 98
2014 109
2015 101
2016 86
2017 77
2018 88
2019 81
2020 76
2021 77
2022 62
2023 58
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

3,354 results

Results by year

Filters applied: . Clear all
Page 1
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, Seaman J. Major P, et al. J Clin Oncol. 2001 Jan 15;19(2):558-67. doi: 10.1200/JCO.2001.19.2.558. J Clin Oncol. 2001. PMID: 11208851
RESULTS: Two hundred eighty-seven patients were randomized and evaluated for safety; 275 were evaluated for efficacy. Both doses of zoledronic acid were superior to pamidronate in the treatment of HCM. The complete response rates by day 10 were 88.4% (P = .002), 86. …
RESULTS: Two hundred eighty-seven patients were randomized and evaluated for safety; 275 were evaluated for efficacy. Both doses of zoledron …
Pamidronate.
[No authors listed] [No authors listed] 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000439 Free Books & Documents. Review.
Limited information indicates that maternal doses of pamidronate of 30 mg intravenously produce very low levels in milk. Because pamidronate has a serum half-life of about 3 hours, is highly bound to calcium and is poorly absorbed orally (0.3 to 3% in adults), absor …
Limited information indicates that maternal doses of pamidronate of 30 mg intravenously produce very low levels in milk. Because p …
Preparation, Optimisation, and In Vitro Evaluation of [(18)F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET.
Hassan H, Othman MF, Abdul Razak HR, Zakaria ZA, Ahmad Saad FF, Osman MA, Yi LH, Ashhar Z, Idris J, Abdul Hamid MHN, Safee ZM. Hassan H, et al. Molecules. 2022 Nov 17;27(22):7969. doi: 10.3390/molecules27227969. Molecules. 2022. PMID: 36432069 Free PMC article.
NOTA-pamidronic acid was successfully prepared and radiolabeled with (18)F. ...It was found that [(18)F]NaF was higher in both cell lines, but [(18)F]AlF-NOTA-pamidronic acid showed promising cellular uptake in Saos-2. The preliminary results suggest t …
NOTA-pamidronic acid was successfully prepared and radiolabeled with (18)F. ...It was found that [(18)F]NaF was higher in both …
Atrial fibrillation in patients treated with intravenous zoledronic or pamidronic acid: a pharmacoepidemiological study.
Pijnenburg L, Salem JE, Lebrun-Vignes B, Sibilia J, Javier RM, Arnaud L. Pijnenburg L, et al. Eur J Endocrinol. 2021 Mar;184(3):437-444. doi: 10.1530/EJE-20-0650. Eur J Endocrinol. 2021. PMID: 33449911
OBJECTIVE: Atrial fibrillation (AF) may be triggered by intravenous bisphosphonates (IVBPs) such as zoledronic acid or pamidronic acid. Our objective was to confirm the association between AF and IVBPs in a real-life large pharmacovigilance database. ...Most …
OBJECTIVE: Atrial fibrillation (AF) may be triggered by intravenous bisphosphonates (IVBPs) such as zoledronic acid or pamidronic …
Updates on Paget's Disease of Bone.
Choi YJ, Sohn YB, Chung YS. Choi YJ, et al. Endocrinol Metab (Seoul). 2022 Oct;37(5):732-743. doi: 10.3803/EnM.2022.1575. Epub 2022 Oct 25. Endocrinol Metab (Seoul). 2022. PMID: 36327984 Free PMC article.
The diagnosis is frequently confirmed by radiographic and nuclear scintigraphy of the bone. Further, bisphosphonates such as zoledronic acid and pamidronate are effective for its treatment. Moreover, biochemical monitoring is superior to the symptoms as a recurrence …
The diagnosis is frequently confirmed by radiographic and nuclear scintigraphy of the bone. Further, bisphosphonates such as zoledronic a …
Preparation, Characterization, and Radiolabeling of [(68)Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent.
Ashhar Z, Yusof NA, Ahmad Saad FF, Mohd Nor SM, Mohammad F, Bahrin Wan Kamal WH, Hassan MH, Ahmad Hassali H, Al-Lohedan HA. Ashhar Z, et al. Molecules. 2020 Jun 9;25(11):2668. doi: 10.3390/molecules25112668. Molecules. 2020. PMID: 32526838 Free PMC article.
For that, we prepared, thoroughly characterized, and radiolabeled [(68)Ga]Ga-NODAGA-pamidronic acid radiopharmaceutical, a (68)Ga precursor for PET bone cancer imaging applications. ...From previous work, we found that the pamidronic acid itself has a …
For that, we prepared, thoroughly characterized, and radiolabeled [(68)Ga]Ga-NODAGA-pamidronic acid radiopharmaceutical, a (68 …
Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
McKeage K, Plosker GL. McKeage K, et al. Pharmacoeconomics. 2008;26(3):251-68. doi: 10.2165/00019053-200826030-00007. Pharmacoeconomics. 2008. PMID: 18282018 Review.
In patients with advanced breast cancer or multiple myeloma, the incidence of SREs was similar in patients treated with zoledronic acid 4 mg or pamidronic acid 90 mg every 3-4 weeks for up to 25 months but, in breast cancer patients, zoledronic acid re …
In patients with advanced breast cancer or multiple myeloma, the incidence of SREs was similar in patients treated with zoledronic acid …
Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA, Lau CK, Parsons MT, Handlon JJ, Ronquillo YC, Hoopes PC, Moshirfar M. Chartrand NA, et al. J Ocul Pharmacol Ther. 2023 Jan-Feb;39(1):3-16. doi: 10.1089/jop.2022.0094. Epub 2022 Nov 21. J Ocul Pharmacol Ther. 2023. PMID: 36409537 Review.
Only 2nd- and 3rd-generation amino bisphosphonates, including pamidronate, alendronate, risedronate, ibandronate, and zoledronate are associated with these complications. The mechanism of bisphosphonate-induced ocular inflammation may be related to activation of gamma/delt …
Only 2nd- and 3rd-generation amino bisphosphonates, including pamidronate, alendronate, risedronate, ibandronate, and zoledronate are …
3,354 results